ARNAV Biotech, a company based in the United States, is making waves in the biotechnology, health care, and life sciences industries with their innovative approach to mRNA therapeutics and CDRMO. Embracing the slogan "mRNA for all!", they are dedicated to democratizing access to mRNA-based life sciences.
The startup received Non Equity Assistance investment on 26 July 2023, with MassChallenge as the investor. Their forward-thinking vision and emphasis on accessibility make them a compelling player in the evolving landscape of biotech and life sciences.
No recent news or press coverage available for ARNAV Biotech.